Get access

Management of psoriasis in pregnancy

Authors


  • Conflict of Interest Information: Bruce Strober has been a principal investigator, an advisor or consultant, or a speaker for the following groups: Abbott, Amgen, Celgene, Janssen, Maruho, Novartis, Pfizer and UBC.

Address correspondence and reprint requests to: Bruce Strober, MD PhD, Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT 06030, or email: strober@uchc.edu

Abstract

Psoriasis is an inflammatory skin disorder not uncommonly seen in pregnant patients. Several drugs have been approved for its treatment in non-pregnant patients, but special precautions are necessary when selecting a treatment plan during pregnancy to prevent harm to the fetus and child. This article reviews the treatment options for the treatment of psoriasis in the pregnant and lactating patient.

Get access to the full text of this article

Ancillary